Plexin-B1 mutations in prostate cancer.
Wong OG, Nitkunan T, Oinuma I, Zhou C, Blanc V, Brown RS, Bott SR, Nariculam J, Box G, Munson P, Constantinou J, Feneley MR, Klocker H, Eccles SA, Negishi M, Freeman A, Masters JR, Williamson M.
Wong OG, et al.
Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19040-5. doi: 10.1073/pnas.0702544104. Epub 2007 Nov 16.
Proc Natl Acad Sci U S A. 2007.
PMID: 18024597
Free PMC article.
Mutations were found in 89% (8 of 9) of prostate cancer bone metastases, in 41% (7 of 17) of lymph node metastases, and in 46% (41 of 89) of primary cancers. ...Overexpression of the Plexin-B1 protein was found in the majority of primary tumors. The mutations hinder …
Mutations were found in 89% (8 of 9) of prostate cancer bone metastases, in 41% (7 of 17) of lymph node metastases, and in 46% …